CHERIE SLOAN: Open Payments
NPI 1265031470 · VOORHEES, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,183 in 46 payments from 11 companies in 2025. Trend: 2023 $314 · 2024 $127 · 2025 $1,183
Food & beverage: $1,073Education: $110
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $338 |
| UCB, Inc. | 4 | $158 |
| GENZYME CORPORATION | 2 | $145 |
| Organon LLC | 9 | $134 |
| Journey Medical Corporation | 1 | $125 |
| Janssen Biotech, Inc. | 2 | $115 |
| Amgen Inc. | 5 | $84 |
| Lilly USA, LLC | 2 | $39 |
| Botanix SB Inc | 1 | $16 |
| LEO Pharma Inc. | 1 | $15 |
Products named: SKYRIZI, DUPIXENT, Bimzelx, TREMFYA, Otezla, RINVOQ, VTAMA, TALTZ.
Industry payments across NJ — which companies pay providers there.
